Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menéndez C, Nambozi M, Valéa I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U. Bassat Q, et al. Among authors: bacchieri a. PLoS One. 2009 Nov 17;4(11):e7871. doi: 10.1371/journal.pone.0007871. PLoS One. 2009. PMID: 19936217 Free PMC article. Clinical Trial.
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Valecha N, Phyo AP, Mayxay M, Newton PN, Krudsood S, Keomany S, Khanthavong M, Pongvongsa T, Ruangveerayuth R, Uthaisil C, Ubben D, Duparc S, Bacchieri A, Corsi M, Rao BH, Bhattacharya PC, Dubhashi N, Ghosh SK, Dev V, Kumar A, Pukrittayakamee S. Valecha N, et al. Among authors: bacchieri a. PLoS One. 2010 Jul 30;5(7):e11880. doi: 10.1371/journal.pone.0011880. PLoS One. 2010. PMID: 20689583 Free PMC article. Clinical Trial.
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Gargano N, Ubben D, Tommasini S, Bacchieri A, Corsi M, Bhattacharyya PC, Rao BH, Dubashi N, Dev V, Ghosh SK, Kumar A, Srivastava B, Valecha N. Gargano N, et al. Among authors: bacchieri a. Malar J. 2012 Jul 20;11:233. doi: 10.1186/1475-2875-11-233. Malar J. 2012. PMID: 22818552 Free PMC article. Clinical Trial.
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE, Evans AM, Shakib S, Lungershausen Y, Francis B, Valentini G, Bacchieri A, Ubben D, Pace S. Reuter SE, et al. Among authors: bacchieri a. Clin Drug Investig. 2015 Sep;35(9):559-67. doi: 10.1007/s40261-015-0312-8. Clin Drug Investig. 2015. PMID: 26293519 Clinical Trial.
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
Vignier N, Bouchaud O, Angheben A, Bottieau E, Calleri G, Salas-Coronas J, Martin C, Ramos JM, Mechain M, Rapp C, Nothdurft HD, Velasco M, Bardají A, Rojo-Marcos G, Visser LG, Hatz C, Bisoffi Z, Jelinek T, Duparc S, Bourhis Y, Tommasini S, Iannucelli M, Bacchieri A, Mattera GG, Merlo Pich E, Behrens RH. Vignier N, et al. Among authors: bacchieri a. Malar J. 2021 May 8;20(1):214. doi: 10.1186/s12936-021-03750-x. Malar J. 2021. PMID: 33964945 Free PMC article.
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
Blair JE, Macarie C, Ruzyllo W, Bacchieri A, Valentini G, Bianchetti M, Pang PS, Harinstein ME, Sabbah HN, Filippatos GS, Gheorghiade M; HORIZON-HF investigators. Blair JE, et al. Among authors: bacchieri a. Am J Ther. 2008 May-Jun;15(3):231-40. doi: 10.1097/MJT.0b013e31816d9186. Am J Ther. 2008. PMID: 18496261 Clinical Trial.
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.
Staessen JA, Thijs L, Stolarz-Skrzypek K, Bacchieri A, Barton J, Espositi ED, de Leeuw PW, Dłużniewski M, Glorioso N, Januszewicz A, Manunta P, Milyagin V, Nikitin Y, Souček M, Lanzani C, Citterio L, Timio M, Tykarski A, Ferrari P, Valentini G, Kawecka-Jaszcz K, Bianchi G. Staessen JA, et al. Among authors: bacchieri a. Trials. 2011 Jan 14;12:13. doi: 10.1186/1745-6215-12-13. Trials. 2011. PMID: 21235787 Free PMC article. Clinical Trial.
OASIS-HT: design of a pharmacogenomic dose-finding study.
Staessen JA, Kuznetsova T, Acceto R, Bacchieri A, Brand E, Burnier M, Celis H, Citterio L, de Leeuw PW, Filipovský J, Fournier A, Kawecka-Jaszcz K, Manunta P, Nikitin Y, O'Brien ET, Redón J, Thijs L, Ferrari P, Valentini G, Bianchi G. Staessen JA, et al. Among authors: bacchieri a. Pharmacogenomics. 2005 Oct;6(7):755-75. doi: 10.2217/14622416.6.7.755. Pharmacogenomics. 2005. PMID: 16207152 Clinical Trial.
The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials.
Panetta V, Bacchieri A, Papetti S, De Stefani E, Navarra P. Panetta V, et al. Among authors: bacchieri a. Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):963-973. doi: 10.26355/eurrev_202001_20082. Eur Rev Med Pharmacol Sci. 2020. Retraction in: Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6443. doi: 10.26355/eurrev_202111_27130 PMID: 32017005 Free article. Retracted.
15 results